Skip to main content
Not yet activatedNot yet activated

Cashews

Cashews

Overview​

Cashews provide plant protein, magnesium, zinc, and unsaturated fats in a tree-nut matrix. Soaking and sprouting can reduce phytates, improving mineral bioavailability from nuts and seeds.

Within the BRAIN Diet framework, cashews are a lysine-limited plant protein source paired with legumes or grains for amino-acid complementarity.

Key Nutritional Highlights​

  • Magnesium and zinc in a tree-nut matrix; typical portions are 30–40 g, not 100 g.
  • Lysine-limited plant protein; pair with legumes for amino-acid balance.
  • Soaking/sprouting reduces phytates and can improve mineral bioavailability.
  • Unsaturated fat source; energy-dense — portion control matters.

Food Context​

Synergies​

  • Soak to reduce phytates and improve zinc bioavailability; soaking and sprouting reduces phytates in legumes/grains, improving non-heme iron and zinc bioavailability
  • Part of diverse nut/seed intake; dietary diversity (≥30 plant foods per week) supports microbial richness and resilience
  • Pair with animal proteins or vitamin C for better zinc absorption

Preparation​

  • Supports zinc sufficiency; zinc is critical for neurotransmitter modulation, synaptic plasticity, and antioxidant enzyme function

Essential Amino Acid Profile​

Cashews provide plant protein but are not a complete protein; lysine is typically limiting for nuts and seeds.

Protein pairing strategy:

Pair with legumes or grains to complete essential amino acid coverage.

Recipes​

no recipes found

Nutrient Tables (per 100 g)

Selected food and preparation: Nuts, cashew nuts, raw. per 100 g edible portion.

Core nutrients

NutrientAmount per 100 g% reference intake per 100 g
Energy553 kcal—
Protein18.2 g—
Total fat43.9 g—
Saturated fat7.8 g—
Carbohydrates30.2 g—
Sugars5.9 g—
Fibre3.3 g—

Key vitamins and minerals

Vitamins and minerals supplying at least 10% of an adult reference intake per 100 g, derived from the composition panel.

NutrientAmount per 100 g% reference intake per 100 g
Iron6.7 mg37.1%
Zinc5.8 mg52.5%
Magnesium292 mg69.5%
Phosphorus593 mg84.7%
Manganese1.7 mg72%
Selenium19.9 µg36.2%
Potassium660 mg19.4%
Copper2.2 mg243.9%
Vitamin B60.4 mg32.1%
Vitamin B10.4 mg35.3%
Vitamin B50.9 mg17.3%
Vitamin K34.1 µg28.4%

Bioactive compounds

Content applies to the food and preparation identified in the source notes.

Compound / classAmount per 100 gNotes
Linoleic Acid7.8 g—
Reference intakes: US Dietary Reference Intakes for adults (19–50 years; using the higher of male/female values where they differ).
Composition source: USDA FoodData Central, Nuts, cashew nuts, raw, FDC ID 170162, per 100 g edible portion

Substances​

7 substances in this food
Cu2+

Copper

USDA FoodData Central reports copper in Nuts, cashew nuts, raw.

Fe2+

Iron

USDA FoodData Central reports iron in Nuts, cashew nuts, raw.

Mg2+

Magnesium

USDA FoodData Central reports magnesium in Nuts, cashew nuts, raw.

Mn2+

Manganese

USDA FoodData Central reports manganese in Nuts, cashew nuts, raw.

Zn2+

Zinc

USDA FoodData Central reports zinc in Nuts, cashew nuts, raw.

References​

Food composition → admitted dietary relationships

These links join food composition to existing PM admissions. They do not establish that a portion reproduces an intervention, delivers an intact cofactor to tissue, or improves a clinical outcome. Derived supply retains its conversion and delivery limits.

  • Iron → BRS1-FM1-PM3 · Type A / direct
    Food form & relationship limits

    Human intake-to-dopamine responsiveness and clinical benefit were not established; the direct dopamine-metabolite evidence assessed here is preclinical deficiency evidence.

    Nuts, cashew nuts, raw; raw.

  • Magnesium → BRS1-FM1-PM3 · Type A / direct
    Food form & relationship limits

    Catalytic capacity does not show that extra dietary magnesium increases regional catecholamine clearance or improves function. COMT isoforms, genotype, SAM availability and tissue homeostasis constrain interpretation; increased clearance is not universally desirable.

    Nuts, cashew nuts, raw; raw.

  • Iron → BRS1-FM1-PM4 · direct
    Food form & relationship limits

    Human intake-to-noradrenaline responsiveness and clinical benefit were not established; the cited dopamine-metabolite and developmental evidence is not a noradrenaline-dosing trial.

    Nuts, cashew nuts, raw; raw.

  • Copper → BRS1-FM1-PM4 · Type A / direct
    Food form & relationship limits

    Copper is required by the enzyme. Genetic copper-trafficking disease and animal deficiency models are not evidence that extra dietary copper raises brain noradrenaline when copper status is adequate.

    Nuts, cashew nuts, raw; raw.

  • Magnesium → BRS1-FM1-PM4 · Type A / direct
    Food form & relationship limits

    Catalytic capacity does not show that extra dietary magnesium increases regional catecholamine clearance or improves function. COMT isoforms, genotype, SAM availability and tissue homeostasis constrain interpretation; increased clearance is not universally desirable.

    Nuts, cashew nuts, raw; raw.

  • Iron → BRS1-FM1-PM5 · Type A / direct
    Food form & relationship limits

    Iron is required by the hydroxylase. That is not evidence that extra dietary iron raises brain serotonin when iron status is adequate.

    Nuts, cashew nuts, raw; raw.

  • Magnesium → BRS1-FM4-PM11 · Type A / direct
    Food form & relationship limits

    Neuronal ion-manipulation experiments establish physiological capacity, not oral magnesium delivery at a pharmacological concentration, treatment of excitotoxic injury or benefit above adequacy. Brain homeostasis and membrane voltage remain determinants; more NMDA inhibition is not automatically beneficial.

    Nuts, cashew nuts, raw; raw.

  • Zinc → BRS2-FM1-PM2 · Type A / direct
    Food form & relationship limits

    Human purified-enzyme metal removal/reconstitution and ligand mutants establish zinc-dependent capacity. Dietary zinc supplies the same element, but no human extra-intake BHMT flux response, intake threshold or cognitive benefit is established.

    Nuts, cashew nuts, raw; raw.

  • Magnesium → BRS2-FM1-PM3 · Type A / direct
    Food form & relationship limits

    Human MAT structural and enzymological evidence establishes catalytic capacity. Ordinary food supply is distinct from measured MAT flux; no benefit from additional magnesium in replete people or universal methylation increase is asserted.

    Nuts, cashew nuts, raw; raw.

  • Magnesium → BRS2-FM2-PM6 · Type A / direct
    Food form & relationship limits

    Human GSS crystallography and cofactor annotation support capacity. The structure contains two magnesium ions; this does not establish a dietary dose, increased blood or neuronal glutathione synthesis, or benefit above adequacy. Original one-per-subunit wording is retained in history rather than used as dietary stoichiometry.

    Nuts, cashew nuts, raw; raw.

  • Zinc → BRS3-FM2-PM4 · Type A / direct
    Food form & relationship limits

    Curated human SOD1 and experimental structural evidence support a structural capacity relationship, not zinc-dependent catalysis identical to copper. Human dietary SOD responses vary by isoform and status; extra zinc can disturb copper availability. No general oxidative-stress improvement or benefit above adequacy is established.

    Nuts, cashew nuts, raw; raw.

  • Copper → BRS3-FM2-PM4 · direct
    Food form & relationship limits

    Erythrocyte superoxide dismutase rose after copper repletion in infants with marginal copper status. That does not show that extra copper raises the enzyme when status is already adequate.

    Nuts, cashew nuts, raw; raw.

  • Manganese → BRS3-FM2-PM4 · Type A / direct
    Food form & relationship limits

    Human SOD2 requires manganese; dietary depletion experiments measured lower heart and kidney MnSOD activity in rats. This establishes a bounded enzyme-capacity dependency, not a human dose recommendation, universal tissue response, measured net ROS balance or benefit above adequate intake.

    Nuts, cashew nuts, raw; raw.

  • Iron → BRS3-FM2-PM4 · Type A / direct
    Food form & relationship limits

    Rat diet and tissue context; the kidney result is not a uniform response across organs or a human intake threshold. Human catalase haem identity supports capacity, not benefit from extra iron. Iron can also promote non-enzymatic oxidation; higher catalase activity is not a clinical benefit.

    Nuts, cashew nuts, raw; raw.

  • Iron → BRS4-FM1-PM1 · Type A / direct
    Food form & relationship limits

    This identifies iron centres in the chain. It does not show that eating more iron, once iron status is adequate, raises electron transport.

    Nuts, cashew nuts, raw; raw.

  • Copper → BRS4-FM1-PM1 · Type A / direct
    Food form & relationship limits

    Specific complex-IV metal dependence and dietary-deficiency evidence support capacity supply. Rat cardiac protein/activity effects are not a human optimisation dose, a universal tissue response or proof that extra copper improves electron transport when status is adequate.

    Nuts, cashew nuts, raw; raw.

  • Iron → BRS4-FM1-PM10 · Type A / direct
    Food form & relationship limits

    Capacity admission only: no CoQ-specific intake target, rate limitation under adequate nutrition, increased synthesis from extra intake, mitochondrial delivery or clinical benefit is established.

    Nuts, cashew nuts, raw; raw.

  • Manganese → BRS4-FM2-PM5 · Type A / direct
    Food form & relationship limits

    Capacity is supported by protein biochemistry and mouse dietary manipulation; no general-population limitation, extra-intake benefit or human supplement dose is established.

    Nuts, cashew nuts, raw; raw.

  • Zinc → BRS5-FM1-PM1 · Type A / direct
    Food form & relationship limits

    Direct requirement evidence is principally cellular and animal, with human supplementation evidence concentrated in deficiency or disease contexts; higher intake is not established to improve PM1 in zinc-sufficient people.

    Nuts, cashew nuts, raw; raw.

  • Linoleic acid → BRS5-FM3-PM7 · Type B / direct
    Food form & relationship limits

    This is physiological nutrient sensing, not a beneficial direction or a need to increase linoleic acid. Human food-level circuit responses, vagal tone, ADHD and clinical benefits were not established. Foods generally supply esterified fatty acids released during digestion; the experimental free-fatty-acid stimulus is not a demonstrated food effect. More signalling is not automatically better.

    Nuts, cashew nuts, raw; raw.

  • Magnesium → BRS6-FM1-PM3 · Type A / direct
    Food form & relationship limits

    Dietary-depletion evidence is preclinical; extra intake in magnesium-replete humans is not shown here.

    Nuts, cashew nuts, raw; raw.

  • Zinc → BRS-X(ECS-PM1) · Type A / direct
    Food form & relationship limits

    Human enzyme structure and catalysis establish the metal dependency, not dietary zinc-driven brain NAE flux or benefit above adequacy. Cellular zinc homeostasis and membrane substrate access constrain loading; no extra-zinc recommendation is established.

    Nuts, cashew nuts, raw; raw.

  • Zinc → BRS-X(Hormones-PM5) · Type A / direct
    Food form & relationship limits

    This Type A relationship concerns the receptor DNA-binding domain, not stimulation of testosterone production, tissue receptor occupancy, motivation or benefit from extra zinc. Cellular zinc homeostasis and receptor expression constrain metal availability. The primary crystal used an engineered rat receptor domain; human domain identity is curated. A zinc-finger mutation study tested an arginine substitution, not dietary zinc depletion.

    Nuts, cashew nuts, raw; raw.